Authors

• Rina Hui (ORCID: https://orcid.org/0000-0003-0696-7442)
• Caicun Zhou (ORCID: https://orcid.org/0009-0006-1359-1390)
• Roy S. Herbst (ORCID: https://orcid.org/0000-0003-2535-5847)
• Elvire Pons‐Tostivint (ORCID: https://orcid.org/0000-0003-4478-0523)
• Chinyere E. Okpara (ORCID: https://orcid.org/0000-0002-5621-9138)
• Ignacio Casarini (ORCID: https://orcid.org/0000-0002-0479-9417)
• Manuel Cobo (ORCID: https://orcid.org/0000-0003-3402-1144)
• Vladimir Moiseyenko (ORCID: https://orcid.org/0000-0003-4807-7915)
• Mehmet Alı Nahıt Şendur (ORCID: https://orcid.org/0000-0001-7021-6139)
• Delvys Rodríguez‐Abreu (ORCID: https://orcid.org/0000-0003-0506-1366)
• Corina E. Dutcus (ORCID: https://orcid.org/0000-0003-3483-716X)
• Byoung Chul Cho (ORCID: https://orcid.org/0000-0002-5562-270X)
• Mauricio Burotto (ORCID: https://orcid.org/0000-0002-7150-4033)
• Diana Chirovsky (ORCID: https://orcid.org/0000-0003-1641-1990)
• Makoto Nishio (ORCID: https://orcid.org/0000-0003-4969-4165)
• Julia Dudnik
• Lina Yin
• Yiwen Luo (ORCID: https://orcid.org/0000-0002-5187-6841)
• Niyati Bhagwati
• Samreen Ahmed

Institutions

• Tongji University (CN)
• Universidad de Las Palmas de Gran Canaria (ES)
• National Health Service (GB)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Ankara University (TR)
• Bilkent University (TR)
• Yonsei University (KR)
• Hospital Universitario Insular de Gran Canaria (ES)
• Soroka Medical Center (IL)
• University Hospitals of Leicester NHS Trust (GB)
• Centre Hospitalier Universitaire de Nantes (FR)
• Hospital Regional Universitario de Málaga (ES)
• Shanghai Pulmonary Hospital (CN)
• Başkent University Hospital (TR)
• Eisai (United Kingdom) (GB)
• Eisai (United States) (US)
• Centro Científico Tecnológico Mar del Plata (AR)
• Instituto de Investigación Biomédica de Málaga (ES)
• Japanese Foundation For Cancer Research (JP)
• University of Hong Kong (HK)

Publication Details

Journal

Journal of Thoracic Oncology

Published

2025-05-24

DOI

https://doi.org/10.1016/j.jtho.2025.05.016

Citations

6

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

6.27

Funders

• Eli Lilly and Company
• Merck
• Eisai
• Eisai Canada
• Merck Sharp and Dohme